Small et al., 2010 - Google Patents
Myocardin-related transcription factor-a controls myofibroblast activation and fibrosis in response to myocardial infarctionSmall et al., 2010
View PDF- Document ID
- 15912038418938998354
- Author
- Small E
- Thatcher J
- Sutherland L
- Kinoshita H
- Gerard R
- Richardson J
- DiMaio J
- Sadek H
- Kuwahara K
- Olson E
- Publication year
- Publication venue
- Circulation research
External Links
Snippet
Rationale: Myocardial infarction (MI) results in loss of cardiac myocytes in the ischemic zone of the heart, followed by fibrosis and scar formation, which diminish cardiac contractility and impede angiogenesis and repair. Myofibroblasts, a specialized cell type that switches from a …
- 102100013508 MRTFA 0 title abstract description 177
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Small et al. | Myocardin-related transcription factor-a controls myofibroblast activation and fibrosis in response to myocardial infarction | |
Luo et al. | Cooperative binding of ETS2 and NFAT links Erk1/2 and calcineurin signaling in the pathogenesis of cardiac hypertrophy | |
Woodall et al. | Cardiac fibroblast GRK2 deletion enhances contractility and remodeling following ischemia/reperfusion injury | |
He et al. | Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor–specific Arkadia-mediated downregulation of Smad7 | |
Methawasin et al. | Experimentally increasing the compliance of titin through RNA binding motif-20 (RBM20) inhibition improves diastolic function in a mouse model of heart failure with preserved ejection fraction | |
Seneviratne et al. | Interferon regulatory factor 5 controls necrotic core formation in atherosclerotic lesions by impairing efferocytosis | |
Zhao et al. | NADPH oxidase 4 induces cardiac fibrosis and hypertrophy through activating Akt/mTOR and NFκB signaling pathways | |
Mao et al. | Nidogen-2 maintains the contractile phenotype of vascular smooth muscle cells and prevents neointima formation via bridging Jagged1-Notch3 signaling | |
Rodríguez-Vita et al. | Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-β–independent mechanism | |
Gonzalez-Quesada et al. | Thrombospondin-1 induction in the diabetic myocardium stabilizes the cardiac matrix in addition to promoting vascular rarefaction through angiopoietin-2 upregulation | |
Abdel-Malak et al. | Early growth response-1 regulates angiopoietin-1-induced endothelial cell proliferation, migration, and differentiation | |
Van Aelst et al. | Osteoglycin prevents cardiac dilatation and dysfunction after myocardial infarction through infarct collagen strengthening | |
Auguste et al. | Suppression of activated FOXO transcription factors in the heart prolongs survival in a mouse model of laminopathies | |
Ding et al. | Increased expression of integrin-linked kinase attenuates left ventricular remodeling and improves cardiac function after myocardial infarction | |
Lähteenvuo et al. | Vascular endothelial growth factor-B induces myocardium-specific angiogenesis and arteriogenesis via vascular endothelial growth factor receptor-1–and neuropilin receptor-1–dependent mechanisms | |
Li et al. | SIRT1 acts as a modulator of neointima formation following vascular injury in mice | |
Wang et al. | Cartilage oligomeric matrix protein maintains the contractile phenotype of vascular smooth muscle cells by interacting with α7β1 integrin | |
Widyantoro et al. | Endothelial cell–derived endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial-to-mesenchymal transition | |
Huang et al. | Smad3 mediates cardiac inflammation and fibrosis in angiotensin II–induced hypertensive cardiac remodeling | |
Miyamoto et al. | Histone acetyltransferase activity of p300 is required for the promotion of left ventricular remodeling after myocardial infarction in adult mice in vivo | |
Kim et al. | p53 impairs endothelium-dependent vasomotor function through transcriptional upregulation of p66shc | |
Yang et al. | Id proteins are critical downstream effectors of BMP signaling in human pulmonary arterial smooth muscle cells | |
Tucka et al. | Akt1 regulates vascular smooth muscle cell apoptosis through FoxO3a and Apaf1 and protects against arterial remodeling and atherosclerosis | |
Paik et al. | Wnt10b gain-of-function improves cardiac repair by arteriole formation and attenuation of fibrosis | |
Huff et al. | Apolipoprotein C-III: going back to the future for a lipid drug target |